Key statistics
On Thursday, Genelux Corp (GNLX:NAQ) closed at 2.44, 52.50% above the 52 week low of 1.60 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.56 |
---|---|
High | 2.56 |
Low | 2.34 |
Bid | 2.40 |
Offer | 2.50 |
Previous close | 2.49 |
Average volume | 232.49k |
---|---|
Shares outstanding | 34.54m |
Free float | 28.91m |
P/E (TTM) | -- |
Market cap | 84.96m USD |
EPS (TTM) | -0.9537 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
- Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
- Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
- Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
- Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
- Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
- Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
- Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
- Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
- Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
- Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
More ▼